In addition, PRC1 levels were significantly elevated in stage 2 pancreatic cancer patients compared to the cohort without cancer (Figure 2E), though there was no significant difference in expression among different tumor grades (Figure 2F). This evidence concerns the gene PRC1 and familial pancreatic carcinoma.